Trial to evaluate the administration of IDOR-1134-2831 vaccine in healthy participants
ID-090-101
Phase 1 other active
Quick answer
Trial to evaluate the administration of IDOR-1134-2831 vaccine in healthy participants for Clostridioides difficile (C. difficile) is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Clostridioides difficile (C. difficile)
- Phase
- Phase 1
- Modality
- other
- Status
- active